Blue Protocol and Eko Artificial Intelligence Are Best (BEA-BEST)

Part of paid clinical trials in Louisville, Kentucky.

Sponsor
University of Louisville
Study ID
NCT05144633
Status
Recruiting
Apply to this trial

Conditions

  • Acute Respiratory Failure

Eligibility Criteria

Sex
ALL
Age
18 Years - 100 Years
Healthy Volunteers
Not accepted

Interventions

  • Auscultation — DEVICE
    This study will be to determine if the addition of Eko AI-assisted lung auscultation examination to a standard of care Pulmonary POCUS + assists with acute respiratory failure diagnosis.

Study Details

This is an observational study that will be enrolling University of Louisville patients who present to the Emergency Department in Acute Respiratory Failure. This study will be to determine if the addition of Eko AI-assisted lung auscultation examination to a standard of care Pulmonary POCUS + assists with acute respiratory failure diagnosis.

Key Dates

Start date
Sep 9, 2021
Status verified
Jun 2024
Primary completion
Apr 30, 2025
Completion
Apr 30, 2025

Study Design

Enrollment
100 participants (estimated)

Arms

  • Arm: Acute Respiratory failure
    Patients presenting to the Emergency Department in acute respiratory failure. These patients may or may not have a diagnosis of chronic lung disease.

Primary Outcome Measure

Measure the accuracy of POCUS for the diagnosis of acute respiratory failure [ Time Frame: 2 years ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
University of LouisvilleLouisvilleKentucky40202
Rodrigo Cavallazzi, MD
[email protected]
5028525841
Andrea Reyes, MD
[email protected]
5028528884

Find similar trials in Louisville, KY

By research site
University of Louisville· Louisville, KY

Related Studies